Data updated to April 27, 2021
Humanity faces the largest vaccination campaign in history. The immunization process against Covid-19, which began in early December in the United States, United Kingdom, Russia and China, is underway around the world and stands out in most of the richest countries.
Spain started on December 27 the administration of the doses of Pfizer and BioNTech, which has also been reinforced with inoculated doses of the vaccine of Moderna and AstraZeneca. With drugs, it is proposed to immunize the majority of the adult population in Spain. The three vaccines are double-dose: it requires two pricks separated by a period of several weeks. The first people to receive the vaccine in Spain have been the elderly residing in centers for the elderly (who represent around half of the deaths from Covid-19), first-line health personnel and large dependents. After these groups, the general population has begun to be vaccinated, prioritizing the oldest age groups.
The following table shows the status of the vaccination process in Spain in each autonomous community. The percentage of the population completely vaccinated, the percentage of the population with at least one dose of the vaccine, the percentage of doses administered over those received in each autonomous community, the number of injected doses and the registered date of the last dose administered are shown.
From flattening to accelerating the curve
When the pandemic began, there was a main objective for all the countries of the world: to flatten the contagion curve. With the advent of the vaccine, the goal is to accelerate the vaccination curve to immunize millions of people in record time – a logistical and medical challenge never before undertaken on a global scale. Over the weeks, it has been shown that the vaccination bottleneck in Spain is the doses received. This is how the vaccination rate in Spain evolves, measured in the average daily doses administered in the last week.
By Autonomous Communities, the following graph shows the per capita dose curves that must be accelerated in the coming months. This comparison is useful to see if the speed of vaccination increases in each autonomous community (and in Spain in general) but it is less useful to make comparisons between regions since each one can maintain a different vaccination strategy. For example, the autonomous regions that have more residents among the target groups of the first phase (residences and health care) will have received more doses per inhabitant and, in addition, some regions are saving the booster vial to administer it when it is time for the second dose.
How is the vaccination process evolving in your autonomous community? How many people have received at least one dose of the vaccine? Are you picking up the pace of administration? To find out how it is progressing in each autonomous community, each of them can be consulted in the following file. Information is displayed on the number of people who have received the complete vaccination schedule, those who have had at least one injection, the total doses administered, the percentage they represent of the total doses received and the vaccination rate.
The age groups with the most advanced vaccination
Vaccination of the different age groups progresses at a different rate in each autonomous community. People aged 80 and over are those who started receiving the coronavirus vaccine earlier and, therefore, among those who are more advanced in vaccination. A part of the population aged 25 to 65 is also being vaccinated. These are the essential workers, who receive the AstraZeneca vaccine. On the other hand, the vaccination of the 70 to 79-year-old group is further behind, since the current vaccination strategy in Spain dictates that they have to receive the Pfizer or Moderna vaccine, two types that are now being prioritized among octogenarians.
The following table allows the autonomous communities to be ordered according to the percentage of the population of each age group that has received at least one dose or the complete vaccination schedule.
The effect of vaccination on mortality
The doses inoculated in Spain are already beginning to pay off. One of the groups that have received the vaccine has been those over 80 years of age, and among them there is already a greater drop in mortality than among the rest of the population. To a lesser extent, a greater reduction in cases and hospitalizations is also seen in this age group. The following graph compares the evolution of cases, deaths and hospitalizations with Covid-19 by age group. Each curve is adjusted with respect to the maximum peak that each group registered in the third wave.
The road to immunity in the world
Millions of people in a small number of countries around the world have already received at least one dose of some Covid-19 vaccine. The campaign began in many countries in December with emergency authorizations, in some cases using experimental drugs, and which has accelerated in recent weeks with the authorizations of various vaccines in the European Union and the rest of the world.
The following map shows the countries that have administered the most doses per 100 inhabitants worldwide. Only the figures for the countries that have published data are shown, according to the data collected by the portal Our World in Data.
The vaccination gap between rich and poor countries is beginning to show in the figures. So far, the majority of doses administered worldwide are concentrated in the Northern Hemisphere: virtually all of Europe has started vaccinating along with the United States, Canada and much of the Middle East. Precisely, Israel leads the vaccination campaign around the world with 50,000 daily doses which is explained by the digitization of the health system, the distribution of doses to avoid waste and centralization. This table includes the percentage of immunized people in each country, a figure that may differ from the doses per 100 inhabitants, since in many countries vaccines that require two doses are being administered. This percentage cannot be calculated for countries that do not separately show the number of administered doses of each type of vaccine.
The difference between Israel’s vaccination curve and that of other countries is wide. Although the size and population of each country must also be taken into account to make comparisons: it is not the same to vaccinate 8 million people who live concentrated in 22,000 square kilometers than to vaccinate 47 million people who live in 500,000 square kilometers Of surface. To date, Pfizer’s vaccine is the most widespread in Europe and the United States, where Moderna’s vaccine is also being administered. The Oxford / AstraZeneca has also started in the UK. Instead China, India and Russia are using their own drugs that are also distributed by Latin America.
The economic gap becomes more visible when the doses administered are grouped by regions of the world. The vaccination process has barely begun in Latin America and Africa, compared to the countries with the highest per capita income, which accounted for the majority of doses purchased before vaccines were approved.